Our research derived monoclonal antibodies which either enhance or inhibit the lytic activity of a cloned iine of human NK cells. These antibodies, derived from fusions with spleen cells of mice immunized with the NK clone, affect lysis at the level of the killer cell. Two of these antibodies detect class I MHC gene products and two others detect class II MHC gene products; they are apparently unique in that other anticlass I or class II antibodies have no such effects on NK function. This suggests that MHC gene products are involved in some central way in NK function, perhaps serving as primitive receptor structures. It further raises the specific question why these four antibodies, or the epitopes they detect, are so unique. These findings are consistent with a model that a cell surface molecule such as an MHC glycoprotein may exert its functional role in the physiology of different cells via different structural domains of that molecule. It is our plan to examine this possibility using well-characterized human NK clones and a panel of anticlass I, anticlass II, and anti-LFA-1 monoclonal antibodies that detect different determinants on these molecules and which have different effects on NK function. (CS)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA037827-02
Application #
3175680
Study Section
Immunobiology Study Section (IMB)
Project Start
1984-07-01
Project End
1987-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Mahle, N H; Radcliff, G; Sevilla, C L et al. (1989) Kinetics of cellular cytotoxicity mediated by a cloned human natural killer cell line. Immunobiology 179:230-43
Leiden, J M; Karpinski, B A; Gottschalk, L et al. (1989) Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression. J Immunol 142:2140-7
Kornbluth, J; Hoover, R G (1988) Changes in gene expression associated with IFN-beta and IL-2-induced augmentation of human natural killer cell function. J Immunol 141:3234-40
Leiden, J M; Gottesdiener, K M; Quertermous, T et al. (1988) T-cell receptor gene rearrangement and expression in human natural killer cells: natural killer activity is not dependent on the rearrangement and expression of T-cell receptor alpha, beta, or gamma genes. Immunogenetics 27:231-8
Lefkowitz, M; Kornbluth, J; Tomaszewski, J E et al. (1988) Natural killer-cell activity in cyclosporine-treated renal allograft recipients. J Clin Immunol 8:121-7
Taylor, D S; Nowell, P C; Kornbluth, J (1987) Anti-HLA class I antibodies inhibit the T cell-independent proliferation of human B lymphocytes. J Immunol 139:1792-6
Hart, M K; Kornbluth, J; Main, E K et al. (1987) Lymphocyte function-associated antigen 1 (LFA-1) and natural killer (NK) cell activity: LFA-1 is not necessary for all killer: target cell interactions. Cell Immunol 109:306-17
Lefkowitz, M; Jorkasky, D; Kornbluth, J (1987) Increase in natural killer activity in cyclosporine-treated renal allograft recipients during rejection. Hum Immunol 19:139-49
Taylor, D S; Nowell, P C; Kornbluth, J (1986) Functional role of HLA class I cell-surface molecules in human T-lymphocyte activation and proliferation. Proc Natl Acad Sci U S A 83:4446-50
Spear, B T; Kornbluth, J; Strominger, J L et al. (1985) Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131. J Exp Med 162:1802-10